Toshiya Akao
Papers
2
Total Citations
9
H-Index
2
About
Toshiya Akao is a leading urologic surgeon and researcher whose work centers on optimizing surgical outcomes in robot-assisted radical prostatectomy, particularly for high-risk prostate cancer. His major contributions include clarifying the safety of thienopyridine-class antiplatelet agents—such as clopidogrel and prasugrel—during robotic prostatectomy, demonstrating that their use does not significantly increase bleeding complications. This finding, published in 2024 and already cited 7 times, provides crucial guidance for managing patients on these medications. Akao has also advanced understanding of nerve-sparing techniques, showing that neurovascular bundle preservation can be performed safely in high-risk disease without compromising biochemical recurrence rates. His research directly informs clinical decision-making, balancing oncologic control with functional outcomes. With a growing citation impact, Akao’s work is shaping modern urologic oncology practice, offering evidence-based strategies to improve both surgical safety and quality of life for prostate cancer patients.
Research Focus
Key Achievements
Top Papers
- 1
- 2